2019 Annual Meeting | C13 - Clinicopathological Correlation Session in Dementia
Program Materials Program Evaluations
09:30 AM - 09:40 AM EDT | Introduction |
Introduction to Clinicopathological Correlations in Dementia
David Irwin, MD |
09:40 AM - 10:00 AM EDT | Speaker |
Primary Progressive Aphasia
M. M. Mesulam, MD, FAAN |
10:00 AM - 10:20 AM EDT | Speaker |
Lewy Body Disorders
James B. Leverenz, MD, FAAN |
10:20 AM - 10:40 AM EDT | Speaker |
Pathology of AD and Aging
Dirk Keene, MD, PhD |
10:40 AM - 11:30 AM EDT | Speaker |
Case Series Presentations
David Irwin, MD, James B. Leverenz, MD, FAAN, M. M. Mesulam, MD, FAAN, Dirk Keene, MD, PhD |
David Irwin, MD | The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. |
James B. Leverenz, MD, FAAN | Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. |
M. M. Mesulam, MD, FAAN | No disclosure on file |
Dirk Keene, MD, PhD | Dirk Keene, MD, PhD has received publishing royalties from a publication relating to health care. |